Neuphoria Therapeutics (NEUP) Change in Accured Expenses (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported Change in Accured Expenses of -$515,127 for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $2.27 million a year earlier.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Change in Accured Expenses (2023 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics posted Change in Accured Expenses of -$2.58 million.
- By fiscal year, Change in Accured Expenses came in at $1.49 million in FY2025 (+435.0%), $277,854 in FY2024 (+101.2%) and $138,079 in FY2023.
- Five-year quarterly Change in Accured Expenses spans a low of -$1.6 million in fiscal Q2 2026 and a high of $2.27 million in fiscal Q4 2025.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -$1.18 million (Q3 2026), -$1.6 million (Q2 2026) and $718,261 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Neuphoria Therapeutics | 437.56 Mn | 362.37 Mn | - | -515,127.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -515,127.00 |
| Mar 31, 2026 | -1.18 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Sep 30, 2025 | 718,261.00 |
| Jun 30, 2025 | 2.27 Mn |
| Mar 31, 2025 | 375,529.00 |
| Dec 31, 2024 | -786,378.00 |
| Sep 30, 2024 | -367,583.00 |
| Jun 30, 2024 | 498,908.00 |
| Mar 31, 2024 | -474,109.00 |
| Dec 31, 2023 | 957,800.00 |
| Sep 30, 2023 | -704,745.00 |
API Access
Neuphoria Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();